Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 21, 2019 23:07 ET | Source: Kalytera Therapeutics Inc.

Kalytera Provides Update on Private Placement of Common Shares and Common Share Purchase Warrants

SAN FRANCISCO and TEL AVIV, Israel, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the “Company” or “Kalytera”) is pleased to announce that it has...
October 17, 2019 08:30 ET | Source: Kalytera Therapeutics Inc.

Kalytera Terminates Plan to Acquire CBD Extraction Facility

SAN FRANCISCO AND TEL AVIV, Israel, Oct. 17, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") has announced that, due to a...
October 02, 2019 08:30 ET | Source: Kalytera Therapeutics Inc.

Kalytera Announces Notice of Allowance of EU Patent for Prevention and Treatment of Graft Versus Host Disease

SAN FRANCISCO and TEL AVIV, Israel, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") is pleased to announce that the...
September 16, 2019 13:06 ET | Source: Kalytera Therapeutics Inc.

Kalytera Announces Closing of First Tranche of Private Placement of Common Shares and Common Share Purchase Warrants

SAN FRANCISCO and TEL AVIV, Israel, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the “Company” or “Kalytera”) is pleased to announce the...
September 11, 2019 10:50 ET | Source: Kalytera Therapeutics Inc.

Kalytera Announces Update to Private Placement

SAN FRANCISCO and TEL AVIV, Israel, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that it is...
September 09, 2019 21:48 ET | Source: Kalytera Therapeutics Inc.

Kalytera Announces Interest Payment in Shares

SAN FRANCISCO and TEL AVIV, Israel, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that it has...
August 29, 2019 23:25 ET | Source: Kalytera Therapeutics Inc.

Kalytera Reports Second Quarter 2019 Financial Results

SAN FRANCISCO and TEL AVIV, Israel, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") today reported financial results...
August 21, 2019 08:30 ET | Source: Kalytera Therapeutics Inc.

Kalytera Announces Management-Led Private Placement of Up To $1.5 Million of Common Shares and Common Share Purchase Warrants

SAN FRANCISCO and TEL AVIV, Israel, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that it intends to...
August 19, 2019 08:00 ET | Source: Kalytera Therapeutics Inc.

Kalytera to Conclude Phase 2 Clinical Study and Initiate Phase 3 Study

SAN FRANCISCO and TEL AVIV, Israel, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that interim...
July 29, 2019 14:52 ET | Source: Kalytera Therapeutics Inc.

Kalytera Announces Results of Shareholder Meeting Votes

SAN FRANCISCO and TEL AVIV, Israel, July 29, 2019 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the “Company” or “Kalytera”) announced today that shareholder...